DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules.
The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications.
As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides.
Our Technology
The company’s main asset is a specific therapeutic solution for Rheumatoid Arthritis (RA).
Diamante’s technology leverages plant viruses for the production of virus nanoparticles (VNPs) and an innovative therapeutic approach based on the specific induction of the immunological tolerance through the use of specific autoantigenic peptides.
We had pre-clinical evidence of the efficacy of our therapeutic approach and our goal is to enter the human clinical trials by the end of 2023. We are looking for industrial partner to grow together.
Diamante pipeline will explore new therapeutic applications for other autoimmune diseases.
Roberta Zampieri
President and Chief Scientific Officer
Valentina Garonzi
Chief Executive Officer and Managing Director
Linda Avesani
Scientific and R&D advisor
Elisa Gecchele
Scientific Project ManagerMattia Santoni
Industrial PHD studentJohn Butler
VP Open Innovation at Bayer Pharmaceuticals Division at Bayer AGElena Sgaravatti
Founder&CEO Plantarei Biotech Srl PadovaPatrizia Tammaro Silva
Investor relator officer
AWARDS
G-Factor 2019 e Seed Investor
Programma di accelerazione
G-Factor 2019 e Seed Investor
Best Female
Startup 2018
Premio Corporate
Gaetano Marzotto 2016
eit Health Innostars Awards
finalista 2017
Gea Consulenti di direzione
Menzione Special Startup 2016
PGMI
Premio Corporate
Gaetano Marzotto 2016
Start Cup Veneto 2015
2° premio
Unicredit Start Lab 2015
1° premio
UK-Italy Business Awards
Entrepreneurship Award
PNI Cosenza 2015
1° premio
“pari opportunità“
GSVC
Menzione speciale
“migliore idea nel settore health”
Premio Marisa Bellisario
“Germoglio d’oro”
PARTNERS E GRANTS
PHARMA FACTORY
Molecular FarmingBuilding the product pipeline for commercial demonstration of Plant Molecular Factories
14 partners, 7 countries, 5 SMEs, 3 public research institutions and 6 universities
Incubated by MASS CHALLENGE
ìGlobal network for innovators. They equip bold entrepreneurs to disrupt the status quo and create meaningful change. With more than a decade of experience, they proven methodology accelerates the innovation potential of high-growth businesses and startups as they address biggest challenges
Incubated by LE VILLAGE by CA TRIVENETO
2018/19One year of acceleration program to boost the business, create new industrial partnership and grow internationally